Heat shock protein 90 as a molecular target for cancer therapeutics-Reference-Cited by-同舟云学术

Heat shock protein 90 as a molecular target for cancer therapeutics

Published:2003-03 Issue:3 Volume:3 Page:213-217
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Isaacs Jennifer S,Xu Wanping,Neckers Len

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference41 articles.

1. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts;Baselga;Cancer Res.,1998

2. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2;Basso;Oncogene,2002

3. The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy;Blagosklonny;Leukemia,2001

4. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins;Connell;Nat. Cell Biol.,2001

5. ATP induces a conformational change of the 90-kDa heat shock protein (hsp90);Csermely;J. Biol. Chem.,1993

Cited by 532 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of inorganic metal nanomaterials in biological imaging and photothermal therapy;SCIENTIA SINICA Chimica;2024-01-08

2. Investigation of the anti-cancer potential of epoxyazadiradione in neuroblastoma: experimental assays and molecular analysis;Journal of Biomolecular Structure and Dynamics;2023-09-27

3. An HSP90 Inhibitor Overcomes FLT3 Inhibitor Resistance in FLT3/ITD-Positive Leukemia Cells with an N676K Mutation;International Journal of Translational Medicine;2023-09-07

4. Molecular determinants of the response of cancer cells towards geldanamycin and its derivatives;Chemico-Biological Interactions;2023-09

5. Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance;Cell Discovery;2023-07-18